Two recent papers show that probiotics colonize the gut in permissive volunteers only and delay the reconstitution of the microbiome after antibiotics treatment. In the absence of any clinical readouts, it is still difficult to extrapolate these observations in terms of short-term or long-term health consequences for patients.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
FAM3D is essential for colon homeostasis and host defense against inflammation associated carcinogenesis
Nature Communications Open Access 20 November 2020
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cai, J. et al. Comparative efficacy and tolerability of probiotics for antibiotic-associated diarrhea: systematic review with network meta-analysis. United European Gastroenterol. J. 6, 169–180 (2018).
Goldenberg, J. Z. et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst. Rev. 12, CD006095 (2017).
Zmora, N. et al. Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell 174, 1388–1405 (2018).
Suez, J. et al. Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT. Cell 174, 1406–1423 (2018).
van Baarlen, P. et al. Human mucosal in vivo transcriptome responses to three lactobacilli indicate probiotic modulatory capacities and therapeutic potential. Proc. Natl Acad. Sci. USA 108 (Suppl. 1), 4562–4569 (2011).
Hod, K. et al. A double-blind, placebo-controlled study to assess the effect of a probiotic mixture on symptoms and inflammatory markers in women with diarrhea-predominant IBS. Neurogastroenterol. Motil. 29, e13037 (2017).
Sherf-Dagan, S. et al. Probiotics administration following sleeve gastrectomy surgery: a randomized double-blind trial. Int. J. Obes. (Lond.) 42, 147–155 (2018).
Szajewska, H. & Kołodziej, M. Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults. Aliment. Pharmacol. Ther. 42, 1149–1157 (2015).
Selinger, C. P. et al. Probiotic VSL#3 prevents antibiotic-associated diarrhoea in a double-blind, randomized, placebo-controlled trial. J. Hosp. Infect. 84, 159–165 (2013).
Hiippala, K. et al. The potential of gut commensals in reinforcing intestinal barrier function and alleviating inflammation. Nutrients 10, 988 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Langella, P., Chatel, JM. Risk assessment of probiotics use requires clinical parameters. Nat Rev Gastroenterol Hepatol 16, 202–204 (2019). https://doi.org/10.1038/s41575-019-0111-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41575-019-0111-4
This article is cited by
-
Evaluating the Role of Postbiotics in the Modulation of Human Oral Microbiota: A Randomized Controlled Clinical Trial
Probiotics and Antimicrobial Proteins (2024)
-
Evaluation of the therapeutic effect and dose–effect of Bifidobacterium breve on the primary Clostridioides difficile infected mice
Applied Microbiology and Biotechnology (2021)
-
FAM3D is essential for colon homeostasis and host defense against inflammation associated carcinogenesis
Nature Communications (2020)
